Explore All 191 Merger Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | March 30, 2023 |
| Target | EIP Pharma |
| Sector | Life Science |
| Buyer(s) | CervoMed |
| Deal Type | Merger |
| Advisor(s) | Mintz Levin Cohn Ferris Glovsky and Popeo (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2001 |
| Sector | Life Science |
| Employees | 15 |
CervoMed is a biotechnology company develops new treatments to improve the body’s ability to bring oxygen to the areas where it is needed most, offering new hope for the treatment of life-threatening medical conditions. CervoMed was founded in 2001 and is based in Boston, Massachusetts.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 2 of 2 |
| Type: Merger | 2 of 2 |
| State: Massachusetts | 1 of 1 |
| Country: United States | 2 of 2 |
| Year: 2023 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-08 |
RestorGenex
Buffalo Grove, Illinois, United States RestorGenex Corp. is a biopharmaceutical company with an initial focus on dermatology, ocular diseases and women's health. RestorGenex is based in Buffalo Grove, Illinois. |
Buy | - |
